Home›Research›Compare›KPV vs Teduglutide
Peptide ComparisonKPV vs Teduglutide
Both are Tissue Repair peptides.
KPV
Lys-Pro-Val
Half-life: Short (minutes to hours)
102 providers listed
Teduglutide
Gattex
Half-life: ~2 hours
No providers listed yet
Teduglutide is FDA-approved, while KPV is nomination withdrawn — the clearest structural difference between them.
KPV
Evidence
Half-life
Short (minutes to hours)
Teduglutide
Evidence
Half-life
~2 hours
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Teduglutide |
| Further along in FDA review | Teduglutide |
| Oral administration option | KPV |
| More provider options (102 vs 0) | KPV |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
KPV
Teduglutide
KPV
Lysine-proline-valine peptide attenuates hepatic lipid accumulation through ROS-dependent regulation of the P…
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodyb…
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodyb…
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodyb…
+2 more
Teduglutide
From childhood to adulthood in chronic intestinal failure: A nationwide study.
A Long-Acting Glucagon-like Peptide 2 Protracted by Coomassie Brilliant Blue to Enhance Intestinal Growth in…
PERCC1-associated enteropathy: Diagnostic challenges and enteral autonomy achieved with teduglutide.
Glucagon-like peptide agonists and use in short bowel syndrome - what about the side effects?
+5 more
About KPV
Derived from alpha-MSH; binds melanocortin receptors MC1R/MC3R to suppress NF-κB and inflammatory cytokines
About Teduglutide
GLP-2 receptor agonist; stimulates intestinal epithelial proliferation and reduces apoptosis; increases intestinal blood flow and inhibits gastric motility
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
KPV
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Teduglutide
No established clinical contraindications
Under clinical review
Being verified by our medical team before we display monitoring guidance for this peptide.
KPV
Teduglutide
Not enough vendor pricing yet.
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Tissue Repair Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 22, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). KPV vs Teduglutide — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/kpv/teduglutide